Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ADX NYSE:DNP NASDAQ:IBB OTCMKTS:PSHZF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADXAdams Diversified Equity Fund$25.87-0.4%$25.38$20.91▼$26.49$3.18B1.01275,641 shs352,069 shsDNPDNP Select Income Fund$11.10+0.9%$10.84$9.69▼$11.16$4.15B0.34668,948 shs464,188 shsIBBiShares Biotechnology ETF$188.14-0.4%$179.53$130.25▼$199.05$9.41B0.71.64 million shs1.70 million shsPSHZFPershing Square$49.52+1.6%$51.91$48.12▼$68.25$8.92B1.0311,015 shs3,750 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADXAdams Diversified Equity Fund-1.38%-0.85%+4.48%+5.54%+18.15%DNPDNP Select Income Fund-0.16%-0.61%+1.63%+2.72%+12.48%IBBiShares Biotechnology ETF+1.06%-0.28%+6.11%+11.31%+39.56%PSHZFPershing Square-3.94%-7.50%-1.95%-14.89%-15.51%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADXAdams Diversified Equity Fund$25.87-0.4%$25.38$20.91▼$26.49$3.18B1.01275,641 shs352,069 shsDNPDNP Select Income Fund$11.10+0.9%$10.84$9.69▼$11.16$4.15B0.34668,948 shs464,188 shsIBBiShares Biotechnology ETF$188.14-0.4%$179.53$130.25▼$199.05$9.41B0.71.64 million shs1.70 million shsPSHZFPershing Square$49.52+1.6%$51.91$48.12▼$68.25$8.92B1.0311,015 shs3,750 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADXAdams Diversified Equity Fund-1.38%-0.85%+4.48%+5.54%+18.15%DNPDNP Select Income Fund-0.16%-0.61%+1.63%+2.72%+12.48%IBBiShares Biotechnology ETF+1.06%-0.28%+6.11%+11.31%+39.56%PSHZFPershing Square-3.94%-7.50%-1.95%-14.89%-15.51%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADXAdams Diversified Equity Fund 0.00N/AN/AN/ADNPDNP Select Income Fund 0.00N/AN/AN/AIBBiShares Biotechnology ETF 2.70Moderate Buy$188.14N/APSHZFPershing Square 2.00Hold$40.00-19.23% DownsideCurrent Analyst Ratings BreakdownLatest PSHZF, IBB, DNP, and ADX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/7/2026PSHZFPershing Square Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/26/2026PSHZFPershing Square UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$40.005/26/2026PSHZFPershing Square Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageSector Perform5/26/2026PSHZFPershing Square Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold(Data available from 7/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADXAdams Diversified Equity FundN/AN/AN/AN/AN/AN/ADNPDNP Select Income FundN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/APSHZFPershing Square$166.78M54.33$14.03 per share3.53$82.26 per share0.60Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADXAdams Diversified Equity FundN/AN/AN/AN/AN/AN/AN/AN/AN/ADNPDNP Select Income FundN/AN/AN/AN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AN/APSHZFPershing Square$2.53BN/AN/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthADXAdams Diversified Equity Fund$1.877.23%N/AN/AN/ADNPDNP Select Income Fund$0.787.03%N/AN/AN/AIBBiShares Biotechnology ETF$0.410.22%N/AN/AN/APSHZFPershing Square$0.731.47%N/AN/AN/ALatest PSHZF, IBB, DNP, and ADX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/15/2026DNPDNP Select Income Fundmonthly$0.06507.28%9/30/20269/30/202610/13/20266/15/2026DNPDNP Select Income Fundmonthly$0.06507.28%8/31/20268/31/20269/10/20267/16/2026ADXAdams Diversified Equity Fundquarterly$0.507.7%7/27/20267/27/20268/28/20266/15/2026DNPDNP Select Income Fundmonthly$0.06507.28%7/31/20267/31/20268/10/20266/12/2026IBBiShares Biotechnology ETFQuarterly$0.02380.06%6/15/20266/15/20266/18/20261/1/2100DNPDNP Select Income Fundmonthly$0.06509.1%2/28/20242/29/20243/11/20241/1/2100DNPDNP Select Income Fundmonthly$0.06508.62%1/30/20241/31/20242/12/2024(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADXAdams Diversified Equity FundN/AN/AN/ADNPDNP Select Income FundN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/APSHZFPershing Square0.242.492.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADXAdams Diversified Equity Fund28.41%DNPDNP Select Income Fund8.51%IBBiShares Biotechnology ETF62.45%PSHZFPershing Square0.03%Insider OwnershipCompanyInsider OwnershipADXAdams Diversified Equity Fund0.14%DNPDNP Select Income Fund0.02%IBBiShares Biotechnology ETFN/APSHZFPershing SquareN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADXAdams Diversified Equity Fund30122.52 million122.35 millionNot OptionableDNPDNP Select Income Fund590376.82 million376.75 millionNot OptionableIBBiShares Biotechnology ETFN/A49.80 millionN/AOptionablePSHZFPershing SquareN/A182.96 millionN/ANot OptionablePSHZF, IBB, DNP, and ADX HeadlinesRecent News About These CompaniesPershing Square to Announce Second Quarter 2026 Results on August 13, 2026July 23 at 5:00 PM | businesswire.comPershing Square Holdings, Ltd. Confirms Third Quarter 2026 Dividend for ShareholdersJuly 20, 2026 | businesswire.comPershing Square (PS) Stock Looks Overvalued After Its 42% RallyJuly 19, 2026 | finance.yahoo.comPershing Square (OTCMKTS:PSHZF) Stock Crosses Below 50-Day Moving Average - Time to Sell?July 16, 2026 | americanbankingnews.comPershing Square Holdings, Ltd. Announces Appointment of Julian Ide as Independent Non-Executive DirectorJune 18, 2026 | businesswire.comUniversal Purchases Part of Bill Ackman’s Pershing Square Shares in UMGJune 4, 2026 | billboard.comBUMG spends $290m buying back stock from Bill Ackman’s Pershing Square, amid fund’s exit from music companyJune 4, 2026 | musicbusinessworldwide.comMUniversal Music Group shares fall after Ackman’s Pershing Square exits remaining stakeJune 4, 2026 | ca.finance.yahoo.comBill Ackman to Sell Remainder of UMG Stock After Pershing Square’s Failed Acquisition BidJune 3, 2026 | billboard.comBIs Pershing Square (PS) Still Worth The Premium Valuation After Recent Choppy Trading PerformanceJune 3, 2026 | finance.yahoo.comBill Ackman’s Pershing Square is selling its remaining Universal Music Group stake, days after UMG rejected its $64B takeover bidJune 3, 2026 | musicbusinessworldwide.comMPershing Square USA, Ltd. Notes Quarterly Communications FormatJune 3, 2026 | finance.yahoo.comPershing Square Holdings, Ltd. Notes Additional Quarterly CommunicationsJune 2, 2026 | businesswire.comUniversal Music rejects takeover bid from Pershing SquareMay 31, 2026 | philstar.comPUniversal Music Rejects Pershing Square's Proposal: Valuation Concerns SurfaceMay 30, 2026 | devdiscourse.comDUniversal Music rejects Bill Ackman Pershing Square’s $65 bln buyout offerMay 30, 2026 | finance.yahoo.comUniversal Music Group’s Board Rejects Pershing Square Offer: ‘It Fundamentally Undervalues UMG’May 30, 2026 | billboard.comBAnalysts see limited upside to Ackman's Pershing Square as they kick off coverageMay 27, 2026 | msn.comBill Ackman's Pershing Square Takes a Stake in MicrosoftMay 15, 2026 | wsj.comPershing Square Holdings to Buyback $100M of StockMay 15, 2026 | marketwatch.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026Rocket Lab’s Stock Drop Comes With a Bullish TwistBy Ryan Hasson | July 10, 2026Carnival's Second Quarter: Is the Stock Still Complicated?By Peter Frank | June 25, 20265 Places Investors Can Hide If the AI Trade Keeps CrackingBy Ryan Hasson | June 29, 2026PSHZF, IBB, DNP, and ADX Company DescriptionsAdams Diversified Equity Fund NYSE:ADX$25.87 -0.11 (-0.41%) Closing price 03:58 PM EasternExtended Trading$26.04 +0.17 (+0.64%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Adams Diversified Equity Fund, Inc. is a publicly owned investment manager. It primarily provides its services to investment companies. The firm is a large advisory firm The firm is actively engaged in businesses, including commodity pool operator or commodity trading advisor. The firm launches equity. NA The firm employs combination of fundamental, technical, quantitative modelling, and macro-economic analysis to make its investment. The firm conduct external research to make its investment. The firm was formerly known as The Adams Express Company. Adams Diversified Equity Fund, Inc. was founded in 1929 and is based in Baltimore, Maryland.DNP Select Income Fund NYSE:DNP$11.10 +0.10 (+0.86%) Closing price 03:59 PM EasternExtended Trading$11.10 0.00 (0.00%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DNP Select Income Fund Inc. is a closed ended balanced mutual fund launched by Virtus Investment Partners, Inc. The fund is managed by Duff & Phelps Investment Management Co. It invests in the public equity and fixed income markets of the United States. For the fixed income portion, the fund invests in bonds. It seeks to invest in stocks of companies operating in the Utility sector. The fund invests in stocks of companies across all market capitalizations. It benchmarks the performance of its portfolio against the S&P 500 Utilities Index and Barclays Capital U.S. Utility Bond Index. DNP Select Income Fund Inc. was formed on November 26, 1986 and is domiciled in the United States.iShares Biotechnology ETF NASDAQ:IBB$188.14 -0.84 (-0.44%) As of 04:00 PM EasterniShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Pershing Square OTCMKTS:PSHZF$49.52 +0.77 (+1.58%) As of 03:52 PM EasternPershing Square Holdings, Ltd. is a closed-ended balanced fund launched and managed by Pershing Square Capital Management, L.P. It invests in public equity and fixed income markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value stocks of companies. For its fixed income portion, the fund primarily invests in convertible securities and debt securities. It also invests through derivatives. The fund employs long/short strategy to create its portfolio. It benchmarks the performance of its portfolio against the S&P 500 Index and HFRX Global Hedge Fund Index. Pershing Square Holdings, Ltd. was formed on February 2, 2012 and is domiciled in Guernsey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Plugging In: How Kinder Morgan Powers Up Profits TSMC’s Price Hikes Could Show Which AI Chip Stocks Have Real Pricing Power AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
